Thomas Uldrick

Thomas Uldrick is a Senior Medical Director in Clinical Development, specializing in oncology and translational sciences at Regeneron, where they have worked since 2024. They previously held the position of Medical Director at Regeneron from 2021 to 2024 and have extensive experience in clinical trials over more than 14 years. Uldrick has served as a Senior Clinician and Clinical Director at the National Cancer Institute and has held academic roles, including Deputy Head and Affiliate Professor at Fred Hutch. They completed a residency in Internal Medicine at Columbia University Medical Center and earned an M.S. in Biostatistics from Columbia University Mailman School of Public Health. Uldrick received their M.D. from the State University of New York Downstate Medical Center College of Medicine.